Recent Advances in Small-Cell Lung Cancer

Recent Advances in Small-Cell Lung Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: Introduction and Identifying Predictive Biomarkers

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 2: Recent Progress in the Treatment of SCLC

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 3: Personal Approach in Treatment Compared to Clinical Trials

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 4: Advice on Toxicity Management for SCLC Therapy

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 5: Use of I/O Regimen in Relapsed/Refractory SCLC

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 6: Data on FDA Approved Therapy for Relapsed/Refractory SCLC

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 7: Role of Newer Agents in the Treatment & Patient Selection

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 8: Unmet Needs and Challenges in Treating R/R SCLC

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

EP. 9: Q & A and Final Thoughts

ByVivek Subbiah, MD, MD Anderson Cancer Center,Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital,Apar Ganti, MD, University of Nebraska Medical Center

August 20th 2020

Trending on OncLive

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

Oral Azacitidine and Cedazuridine Meets Primary Pharmacokinetic End Point in MDS and CMML

Revisit Every OncLive On Air Episode From September 2026

UTRxMYCN M1-14 Nets FDA Dual Designations in Soft Tissue Sarcoma

Optune Pax Is Approved in Japan for Unresectable Locally Advanced Pancreatic Cancer